研报掘金丨国投证券：迈瑞医疗估值有望迎来重估，予“买入-A”评级

Core Viewpoint - Mindray Medical has officially initiated the plan to issue H-shares and list on the main board of the Hong Kong Stock Exchange, marking a key step in its globalization strategy and opening a new journey for value reassessment [1] Group 1: Company Strategy - The development strategy of Mindray Medical is extending from domestic to international markets [1] - The company's focus is shifting from equipment to a combination of equipment and consumables [1]